Related Experiment Video

Updated: Jun 4, 2026

A Test Bed to Examine Helmet Fit and Retention and Biomechanical Measures of Head and Neck Injury in Simulated Impact
07:30

A Test Bed to Examine Helmet Fit and Retention and Biomechanical Measures of Head and Neck Injury in Simulated Impact

Published on: September 21, 2017

Paediatric low speed vehicle run-over fatalities in Queensland

Bronwyn Griffin1, Kerrianne Watt, Belinda Wallis

  • 1Centre for Children's Burns and Trauma Research, The University of Queensland, Brisbane, Australia. b.griffin@uq.edu.au

Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention
|February 1, 2011
PubMed

Insights

Low speed vehicle run-over (LSVRO) incidents are a significant cause of child pedestrian fatalities in Queensland, particularly among very young children. Most occur on private property, often involving parents driving reversing vehicles.

Area of Science:

  • Pediatric injury prevention
  • Traffic safety research
  • Public health surveillance

Background:

  • Child pedestrian fatalities from low-speed vehicle incidents are under-reported in surveillance data.
  • Identifying these specific fatal injury mechanisms is challenging.
  • This study addresses the incidence of these preventable deaths.

Purpose of the Study:

  • To determine the incidence of low speed vehicle run-over (LSVRO) fatalities in children aged 0-15 years in Queensland.
  • To identify characteristics of LSVRO incidents.
  • To inform intervention strategies for this under-reported injury mechanism.

Main Methods:

  • Analysis of child pedestrian fatalities in Queensland from January 2004 to December 2008.
  • Inclusion criteria: children aged 0-15 years involved in low speed vehicle run-over incidents.
  • Data sourced from the Commission for Children and Young People and Child Guardian (CCYPCG).

Main Results:

  • Fifteen LSVRO fatalities occurred between 2004-2008 (rate: 1.67/100,000).
  • The majority of victims were infants and toddlers (0-3 years old).
  • Most incidents (13/15) occurred on private property, often involving reversing vehicles driven by parents.

Conclusions:

  • LSVRO fatalities represent a significant and under-recognized problem in Queensland.
  • Unique data from child death reviews highlight the need for targeted interventions.
  • Continued data collection by CCYPCG will support child advocacy and prevention efforts.
Abstract

More Related Videos

Using a Virtual Reality Walking Simulator to Investigate Pedestrian Behavior06:38

Using a Virtual Reality Walking Simulator to Investigate Pedestrian Behavior

Published on: June 9, 2020

Amplitude-Integrated EEG in Infants at Risk of Hypoxic-Ischemic Encephalopathy: A Feasibility Study in Road and Air Transport in Western Australia05:15

Amplitude-Integrated EEG in Infants at Risk of Hypoxic-Ischemic Encephalopathy: A Feasibility Study in Road and Air Transport in Western Australia

Published on: June 21, 2024

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...